Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1988
The effect of ceruletide on tardive dyskinesia: a double-blind placebo-controlled study
T Matsunaga, S Ohyama, S Takehara, et al.
The British Journal of Dermatology
|
September 30, 2009
Comparison of skin barrier function and sensory nerve electric current perception threshold between IgE-high extrinsic and IgE-normal intrinsic types of atopic dermatitis
T Mori, K Ishida, S Mukumoto, et al.
Mucosal Immunology
|
August 3, 2017
Regulatory T cells with superior immunosuppressive capacity emigrate from the inflamed colon to draining lymph nodes
Y Nakanishi, R Ikebuchi, T Chtanova, et al.
Allergy
|
June 13, 2017
What's in a name? Atopic dermatitis or atopic eczema, but not eczema alone
J I Silverberg, J P Thyssen, A S Paller, et al.
The British Journal of Dermatology
|
December 29, 2016
Three-dimensional evaluation of subclinical extension of extramammary Paget disease: visualization of the histological border and its comparison to the clinical border
T Murata, T Honda, G Egawa, et al.
The British Journal of Dermatology
|
September 30, 2019
Efficacy and safety of dupilumab in Japanese adults with moderate-to-severe atopic dermatitis: a subanalysis of three clinical trials
N Katoh, Y Kataoka, H Saeki, et al.
The British Journal of Dermatology
|
September 27, 2015
The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-controlled study
O Nemoto, M Furue, H Nakagawa, et al.
Science (New York, N.Y.)
|
March 17, 2000
Prostaglandin D2 as a mediator of allergic asthma
T Matsuoka, M Hirata, H Tanaka, et al.
Experimental Dermatology
|
September 28, 2006
Who is really in control of skin immunity under physiological circumstances - lymphocytes, dendritic cells or keratinocytes?
J M Schröder, K Reich, K Kabashima, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 29, 2023
Upadacitinib for moderate-to-severe atopic dermatitis: Stratified analysis from three randomized phase 3 trials by key baseline characteristics
J P Thyssen, D Thaçi, T Bieber, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1988
The effect of ceruletide on tardive dyskinesia: a double-blind placebo-controlled study
T Matsunaga, S Ohyama, S Takehara, et al.
The British Journal of Dermatology
|
September 30, 2009
Comparison of skin barrier function and sensory nerve electric current perception threshold between IgE-high extrinsic and IgE-normal intrinsic types of atopic dermatitis
T Mori, K Ishida, S Mukumoto, et al.
Mucosal Immunology
|
August 3, 2017
Regulatory T cells with superior immunosuppressive capacity emigrate from the inflamed colon to draining lymph nodes
Y Nakanishi, R Ikebuchi, T Chtanova, et al.
Allergy
|
June 13, 2017
What's in a name? Atopic dermatitis or atopic eczema, but not eczema alone
J I Silverberg, J P Thyssen, A S Paller, et al.
The British Journal of Dermatology
|
December 29, 2016
Three-dimensional evaluation of subclinical extension of extramammary Paget disease: visualization of the histological border and its comparison to the clinical border
T Murata, T Honda, G Egawa, et al.
The British Journal of Dermatology
|
September 30, 2019
Efficacy and safety of dupilumab in Japanese adults with moderate-to-severe atopic dermatitis: a subanalysis of three clinical trials
N Katoh, Y Kataoka, H Saeki, et al.
The British Journal of Dermatology
|
September 27, 2015
The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-controlled study
O Nemoto, M Furue, H Nakagawa, et al.
Science (New York, N.Y.)
|
March 17, 2000
Prostaglandin D2 as a mediator of allergic asthma
T Matsuoka, M Hirata, H Tanaka, et al.
Experimental Dermatology
|
September 28, 2006
Who is really in control of skin immunity under physiological circumstances - lymphocytes, dendritic cells or keratinocytes?
J M Schröder, K Reich, K Kabashima, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 29, 2023
Upadacitinib for moderate-to-severe atopic dermatitis: Stratified analysis from three randomized phase 3 trials by key baseline characteristics
J P Thyssen, D Thaçi, T Bieber, et al.
Page
of 4